AVITA Medical, Inc. financial data

Symbol
RCEL on Nasdaq, AVHHL on OTC
Location
28159 Avenue Stanford, Suite 220, Valencia, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 167 % -74.9%
Quick Ratio 24 % -49.1%
Debt-to-equity -39.2K % -32012%
Return On Equity 28K %
Return On Assets -71.5 % -35.6%
Operating Margin -62.4 % +37.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.6M shares +2.42%
Common Stock, Shares, Outstanding 26.6M shares +2.56%
Entity Public Float 203M USD -52.9%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 26.4M shares +2.36%
Weighted Average Number of Shares Outstanding, Diluted 26.4M shares +2.36%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 74.9M USD +38.3%
Cost of Revenue 11.8M USD +56.3%
Research and Development Expense 21.7M USD +2.07%
Selling and Marketing Expense 58.4M USD +17.5%
General and Administrative Expense 29.8M USD -1.93%
Operating Income (Loss) -46.7M USD +14.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -51.6M USD -3.68%
Income Tax Expense (Benefit) 3K USD -96.5%
Net Income (Loss) Attributable to Parent -51.6M USD -3.5%
Earnings Per Share, Basic -1 USD/shares -1.03%
Earnings Per Share, Diluted -1 USD/shares -1.03%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.2M USD -30%
Marketable Securities, Current 3.47M USD -90.5%
Cash, Cash Equivalents, and Short-term Investments 15.7M USD
Accounts Receivable, after Allowance for Credit Loss, Current 11.3M USD +30.1%
Inventory, Net 7.54M USD +12.3%
Other Assets, Current 8K USD -98.5%
Assets, Current 36.3M USD -50.3%
Property, Plant and Equipment, Net 9.69M USD +37.9%
Operating Lease, Right-of-Use Asset 3.13M USD -20.5%
Intangible Assets, Net (Excluding Goodwill) 5.31M USD +874%
Other Assets, Noncurrent 839K USD +77.4%
Assets 58.1M USD -33.8%
Liabilities, Current 62.6M USD +354%
Contract with Customer, Liability, Noncurrent 307K USD -9.71%
Operating Lease, Liability, Noncurrent 2.37M USD -27.7%
Liabilities 71M USD +11.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.08M USD -33.6%
Retained Earnings (Accumulated Deficit) -384M USD -15.5%
Stockholders' Equity Attributable to Parent -12.9M USD -154%
Liabilities and Equity 58.1M USD -33.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.3M USD +50.6%
Net Cash Provided by (Used in) Financing Activities 363K USD -42.5%
Net Cash Provided by (Used in) Investing Activities 10.8M USD -28.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 26.6M shares +2.56%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 820K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12.2M USD -30%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.23M USD -9.08%
Deferred Tax Assets, Valuation Allowance 60.4M USD -4.64%
Deferred Tax Assets, Gross 61.3M USD -4.16%
Operating Lease, Liability 3.74M USD +44%
Depreciation 1.41M USD +99.7%
Payments to Acquire Property, Plant, and Equipment 221K USD -80.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -52.1M USD +12.2%
Lessee, Operating Lease, Liability, to be Paid 4.63M USD +53.8%
Operating Lease, Liability, Current 900K USD +0.56%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.13M USD +52.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.22M USD +12.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +11.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 888K USD +116%
Lessee, Operating Lease, Liability, to be Paid, Year Three 773K USD +13%
Deferred Tax Assets, Operating Loss Carryforwards 45.2M USD -10.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 658K USD +107%
Operating Lease, Payments 991K USD +21.4%
Additional Paid in Capital 374M USD +4.34%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 346K USD +565%
Depreciation, Depletion and Amortization 521K USD +157%
Deferred Tax Assets, Net of Valuation Allowance 904K USD +44.9%
Share-based Payment Arrangement, Expense 12.2M USD +9.11%
Interest Expense 1.25M USD -7.05%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%